TREE NEWS reports: Moderna’s stock more than doubled after a Phase 3 trial showed its cancer vaccine outperformed the standard of care, causing short sellers to lose $4.8 billion. This is a major milestone for the biotech sector, but it is not related to crypto or RWA.
Moderna Stock Surges on Cancer Vaccine Breakthrough
Share on WeChat
Open WeChat → Scan → then tap "…" to send to a chat or Moments.
Tap "…" in the top-right corner to send to a chat or share to Moments.
Related News
13m ago
Nikkei 225 Opens Up 0.7%, KOSPI Gains 2.2%
25m ago
SK Hynix shares rise about 3% in pre-market trading on Nextrade after earnings
28m ago
Nikkei 225 futures rise 1.7% in early trading
35m ago
SK Hynix: 2027 Capex to Rise Significantly vs 2026
35m ago
SK Hynix: Q3 DRAM Average Selling Price Up Over 20% QoQ
43m ago
Seagate Q1 FY2027 Revenue Jumps Over 60% to $4.2B, EPS Hits Record $7.68